pharma news

News

Kelonia's in vivo CAR-T data will feature at ASH

Kelonia only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but will report impressive results at ASH next month.

News

Otsuka joins IgAN market with Voyxact approval in US

Otsuka has claimed FDA approval for its IgAN therapy Voyxact, joining an increasingly crowded market and beating rival Vera Therapeutics to the punch.

News

Torso of doctor with surgical gloves holding prescription pill bottle in one hand and multiple $100 bills in the other

Latest Medicare pricing cuts promise $12bn in savings

The CMS has revealed the prices for the second batch of 15 drugs going through Medicare's negotiation process, promising net savings of 44% on 2024.

News

Data sets up phase 3 trials for Novo's amycretin in diabetes

Novo Nordisk has decided to move its amycretin into pivotal trials in type 2 diabetes after a phase 2 readout.

News

Innovent files high-dose mazdutide for obesity in China

Innovent has filed a new high-strength version of its weight-loss drug mazdutide in China, aiming to help people with severe obesity.

News

Boy in wheelchair, only lower half of his body visible

Novartis' SMA gene therapy cleared for wider use in US

A new FDA approval means Novartis now has a gene therapy option for almost everyone with spinal muscular atrophy (SMA), regardless of their age.

Kelonia's in vivo CAR-T data will feature at ASH

Otsuka joins IgAN market with Voyxact approval in US

Latest Medicare pricing cuts promise $12bn in savings

Data sets up phase 3 trials for Novo's amycretin in diabetes

Innovent files high-dose mazdutide for obesity in China

Novartis' SMA gene therapy cleared for wider use in US

EU clears first drug therapy for rare disease cALD

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks